Topical medicaments comprising protamine and its derivatives

Aerosol compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a propellant. Specified propellants are dichlorodifluoromethane, difluoroethane, and trichlorofluoromethane. The compositions may contain one or more anti-inflammatory or analg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GLASER ERIC MICHAEL, O'MEARA ROBERT ALLEN QUAIN, MARSDEN RICHARD
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GLASER ERIC MICHAEL
O'MEARA ROBERT ALLEN QUAIN
MARSDEN RICHARD
description Aerosol compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a propellant. Specified propellants are dichlorodifluoromethane, difluoroethane, and trichlorofluoromethane. The compositions may contain one or more anti-inflammatory or analgesic substances, e.g. hydrocortisone, preservatives, oils, or emulsifying agents.ALSO:Pharmaceutical compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a topical vehicle. The compositions may contain one or more anti-inflammatory or analgesic substances e.g. hydrocortisone. The compositions may be in the form of ointments, lotions, creams, sticks, emulsions, powders, solutions, spray solutions, nasal spray solutions, aerosols, lozenges, paints for the nose, mouth and pharynx and rectal and vaginal suppositories. In aqueous preparations, the solubility in water of the protamine can be improved by the presence of formaldehyde-bisulphite or formaldehyde-sulphoxylate complex. The pH of the preparations should preferably be neutral or be within the range 4-7. The compositions may contain one or more preservatives and conventional excipients where necessary.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GB1033737A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GB1033737A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GB1033737A3</originalsourceid><addsrcrecordid>eNrjZLAJyS_ITE7MUchNTQHSual5JcUKyfm5BUWZxZl56QoFRfklibmZeakKiXkpCplAyZTUosyyxJLMstRiHgbWtMSc4lReKM3NIO_mGuLsoZtakB-fWlyQmJyal1oS7-5kaGBsbG5s7mhMWAUAc48viA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Topical medicaments comprising protamine and its derivatives</title><source>esp@cenet</source><creator>GLASER ERIC MICHAEL ; O'MEARA ROBERT ALLEN QUAIN ; MARSDEN RICHARD</creator><creatorcontrib>GLASER ERIC MICHAEL ; O'MEARA ROBERT ALLEN QUAIN ; MARSDEN RICHARD</creatorcontrib><description>Aerosol compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a propellant. Specified propellants are dichlorodifluoromethane, difluoroethane, and trichlorofluoromethane. The compositions may contain one or more anti-inflammatory or analgesic substances, e.g. hydrocortisone, preservatives, oils, or emulsifying agents.ALSO:Pharmaceutical compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a topical vehicle. The compositions may contain one or more anti-inflammatory or analgesic substances e.g. hydrocortisone. The compositions may be in the form of ointments, lotions, creams, sticks, emulsions, powders, solutions, spray solutions, nasal spray solutions, aerosols, lozenges, paints for the nose, mouth and pharynx and rectal and vaginal suppositories. In aqueous preparations, the solubility in water of the protamine can be improved by the presence of formaldehyde-bisulphite or formaldehyde-sulphoxylate complex. The pH of the preparations should preferably be neutral or be within the range 4-7. The compositions may contain one or more preservatives and conventional excipients where necessary.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1966</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19660622&amp;DB=EPODOC&amp;CC=GB&amp;NR=1033737A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19660622&amp;DB=EPODOC&amp;CC=GB&amp;NR=1033737A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GLASER ERIC MICHAEL</creatorcontrib><creatorcontrib>O'MEARA ROBERT ALLEN QUAIN</creatorcontrib><creatorcontrib>MARSDEN RICHARD</creatorcontrib><title>Topical medicaments comprising protamine and its derivatives</title><description>Aerosol compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a propellant. Specified propellants are dichlorodifluoromethane, difluoroethane, and trichlorofluoromethane. The compositions may contain one or more anti-inflammatory or analgesic substances, e.g. hydrocortisone, preservatives, oils, or emulsifying agents.ALSO:Pharmaceutical compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a topical vehicle. The compositions may contain one or more anti-inflammatory or analgesic substances e.g. hydrocortisone. The compositions may be in the form of ointments, lotions, creams, sticks, emulsions, powders, solutions, spray solutions, nasal spray solutions, aerosols, lozenges, paints for the nose, mouth and pharynx and rectal and vaginal suppositories. In aqueous preparations, the solubility in water of the protamine can be improved by the presence of formaldehyde-bisulphite or formaldehyde-sulphoxylate complex. The pH of the preparations should preferably be neutral or be within the range 4-7. The compositions may contain one or more preservatives and conventional excipients where necessary.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1966</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAJyS_ITE7MUchNTQHSual5JcUKyfm5BUWZxZl56QoFRfklibmZeakKiXkpCplAyZTUosyyxJLMstRiHgbWtMSc4lReKM3NIO_mGuLsoZtakB-fWlyQmJyal1oS7-5kaGBsbG5s7mhMWAUAc48viA</recordid><startdate>19660622</startdate><enddate>19660622</enddate><creator>GLASER ERIC MICHAEL</creator><creator>O'MEARA ROBERT ALLEN QUAIN</creator><creator>MARSDEN RICHARD</creator><scope>EVB</scope></search><sort><creationdate>19660622</creationdate><title>Topical medicaments comprising protamine and its derivatives</title><author>GLASER ERIC MICHAEL ; O'MEARA ROBERT ALLEN QUAIN ; MARSDEN RICHARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GB1033737A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1966</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GLASER ERIC MICHAEL</creatorcontrib><creatorcontrib>O'MEARA ROBERT ALLEN QUAIN</creatorcontrib><creatorcontrib>MARSDEN RICHARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GLASER ERIC MICHAEL</au><au>O'MEARA ROBERT ALLEN QUAIN</au><au>MARSDEN RICHARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Topical medicaments comprising protamine and its derivatives</title><date>1966-06-22</date><risdate>1966</risdate><abstract>Aerosol compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a propellant. Specified propellants are dichlorodifluoromethane, difluoroethane, and trichlorofluoromethane. The compositions may contain one or more anti-inflammatory or analgesic substances, e.g. hydrocortisone, preservatives, oils, or emulsifying agents.ALSO:Pharmaceutical compositions for the treatment of skin cancer comprise protamine, or a physiologically-compatible salt thereof, and a topical vehicle. The compositions may contain one or more anti-inflammatory or analgesic substances e.g. hydrocortisone. The compositions may be in the form of ointments, lotions, creams, sticks, emulsions, powders, solutions, spray solutions, nasal spray solutions, aerosols, lozenges, paints for the nose, mouth and pharynx and rectal and vaginal suppositories. In aqueous preparations, the solubility in water of the protamine can be improved by the presence of formaldehyde-bisulphite or formaldehyde-sulphoxylate complex. The pH of the preparations should preferably be neutral or be within the range 4-7. The compositions may contain one or more preservatives and conventional excipients where necessary.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GB1033737A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Topical medicaments comprising protamine and its derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A20%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GLASER%20ERIC%20MICHAEL&rft.date=1966-06-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGB1033737A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true